Abstract
Purpose
Dextromethorphan (DXM) is exceptionally bitter, yet the most widely used antitussive agents worldwide. It belongs to BCS class-II of pharmaceutical agents because of its poor water solubility; this is why it is only available in its hydrobromide salt form either in liquid or in solid formulations in the market. This water-soluble salt of the drug releases its content to a greater extent in salivary pH, which increases bitterness perception. This study aimed at designing a more palatable chocolate formulation of DXM, which releases the minimum drug in salivary pH.
Methodology
DXM nano-emulsion prepared using lecithin and Tween-80 was dried and incorporated in placebo chocolates, poured into silicon molds, and refrigerated to have medicated chocolates.
Results
Medicated chocolates had an average weight of 1.757 ± 0.006 g, a thickness of 7.606 ± 0.0175 mm, and hardness of 2.007 ± 0.0102 Kp. The average drug content was 98.707 ± 0.012%. The average particle size of optimized nano-emulsion was 101.145 ± 2.906 nm with an encapsulation efficiency of 75.866 ± 0.543%. Scanning electron microscopy (SEM) revealed the spherical structure of nanoparticles. Fourier transform infrared (FTIR) spectra and differential scanning calorimetry (DSC) thermograms showed no drug-excipient interaction, and X-ray diffraction (XRD) analysis confirmed the amorphous form of the drug in nano-emulsion. The minimal drug was released at salivary pH from chocolate formulation compared to the standard. The Human Panel taste evaluation confirmed better palatability of chocolate than marketed syrup and tablet formulations of DXM.
Conclusion
The novel medicated chocolate of DXM was proven to have a better palatability profile than its marketed formulations.
Similar content being viewed by others
References
Kardos P. Management of cough in adults. Breathe. 2010;7:123–33.
Dicpinigaitis PV. Clinical perspective - cough: an unmet need. Curr Opin Pharmacol. 2015;22:24–8.
Paul I, Beiler J, McMonagle A, Shaffer M, Duda L, Berlin C. Cough and cold remedies for the treatment of acute respiratory infections in young children. Arch Pediatr Adolesc Med. 2007;161:1140–6.
Haraguchi T, Uchida T, Yoshida M, Kojima H, Habara M, Ikezaki H. The utility of the artificial taste sensor in evaluating the bitterness of drugs: correlation with responses of human TASTE2 receptors (hTAS2Rs). Chem Pharm Bull (Tokyo). 2018;66:71–7.
Upadhyaya JD, Singh N, Sikarwar AS, Chakraborty R, Pydi SP, Bhullar RP, et al. Dextromethorphan mediated bitter taste receptor activation in the pulmonary circuit causes vasoconstriction. PLoS One. 2014;9:e110373.
Mennella JA, Spector AC, Reed DR, Coldwell SE. The bad taste of medicines: overview of basic research on bitter taste. Clin Ther. 2013;35:1225–46.
Melis M, Barbarossa IT. Taste perception of sweet, sour, salty, bitter, and umami and changes due to L-arginine supplementation, as a function of genetic ability to taste 6-n-propylthiouracil. Nutrients. 2017;9. https://doi.org/10.3390/nu9060541.
Ayenew Z, Puri V, Kumar L, Bansal A. Trends in pharmaceutical taste masking technologies: a patent review. Recent Pat Drug Deliv Formul. 2009;3:26–39.
Mayank S, Kumar JD. Chocolate formulation as drug delivery system for pediatrics. Indones J Pharm. 2012;23(4):216–24.
Mayank S, Kumar JD. Chocolate formulation as drug delivery system for pediatrics. Indones J Pharm. 2012;23:216–24.
Viswanath V, Narasimharao B, Purushothaman M, Sireesha S. Formulation and evaluation of fexofenadine hydrochloride and paracetamol chocolate for. World J Pharm Res. 2015;4:842–58.
Reddy S, Mounika K, Venkatesham A. Design and fabrication of medicated chocolate formulation by chocolate drug delivery system. Int J Curr Pharm Res. 2017;9:128–33.
Beckett ST. The science of chocolate. 2008. https://doi.org/10.1039/9781847558053.
Chadha R, Gupta S, Pathak N. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies. Drug Dev Ind Pharm. 2012;38:1538–46.
Hu K, Cao S, Hu F, Feng J. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomedicine. 2012;7:3537–45.
Shangguan M, Lu Y, Qi J, Han J, Tian Z, Xie Y, et al. Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin. J Biomater Appl. 2014;28:887–96.
Heo W, Kim JH, Pan JH, Kim YJ. Lecithin-based nano-emulsification improves the bioavailability of conjugated linoleic acid. J Agric Food Chem. 2016;64:1355–60.
Alimentarius, Codex (1981) Codex standards for cocoa products and chocolate. pp 105–1981.
Margulis-Goshen K, Magdassi S. Formation of simvastatin nanoparticles from microemulsion. Nanomed Nanotechnol Biol Med. 2009;5:274–81.
Patel J, Joshi M, Thakkar V, Gohel M, Baldaniya L, Patel A. Medicated chocolate containing cefpodoxime proxetil: a novel solid dosage form for paediatric patient. Proceedings of RK University’s First International Conference on Research & Entrepreneurship (Jan. 5th & Jan. 6th, 2016).
Paaver U, Lust A, Mirza S, Rantanen J, Veski P, Heinämäki J, et al. Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms. Int J Pharm. 2012;431:111–9.
Ranpise NS, Kulkarni NS, Mair PD, Ranade AN. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with β-cyclodextrin and hydroxypropyl-β- cyclodextrin. Pharm Dev Technol. 2010;15:64–70.
Hatanaka J, Chikamori H, Sato H, Uchida S, Debari K, Onoue S, et al. Physicochemical and pharmacological characterization of α-tocopherol-loaded nano-emulsion system. Int J Pharm. 2010;396:188–93.
Zhao L, Wei Y, Huang Y, He B, Zhou Y, Fu J (2013). Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation. Int J Nanomedicine. 8:3769.
Jadhav AJ, Holkar CR, Karekar SE, Pinjari DV, Pandit AB. Ultrasound assisted manufacturing of paraffin wax nanoemulsions: process optimization. Ultrason Sonochem. 2015;23:201–7.
Sun Q, Cai X, Li J, Zheng M, Chen Z, Yu CP. Green synthesis of silver nanoparticles using tea leaf extract and evaluation of their stability and antibacterial activity. Colloids Surf A Physicochem Eng Asp. 2014;444:226–31.
Gangishetty H, Eedara BB, Bandari S. Development of ketoprofen loaded proliposomal powders for improved gastric absorption and gastric tolerance: in vitro and in situ evaluation. Pharm Dev Technol. 2015;20:641–51.
Malladi M, Jukanti R, Nair R, Wagh S, Padakanti H, Mateti A. Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets. Acta Pharma. 2010;60:267–80.
United States Pharmacopeial Convention. USP 32. In: Comm. Revis. US pharmacopeia & national formulary. United States Pharmacopeial Convention, Inc; United States Pharmacopeial Convention. Committee of Revision. (2008). US pharmacopeia & national formulary. Rockville: United States Pharmacopeial Convention, Inc.
Quality Attribute Considerations for Chewable Tablets Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) August 2018 Pharmaceutical Quality/CMC.
Mcgregor RG, Laboratories E. Laboratory products. Comput Healthc. 1993;14:26–7.
Gittings S, Turnbull N, Roberts CJ, Gershkovich P. Dissolution methodology for taste masked oral dosage forms. J Control Release. 2014;173:32–42.
Guhmann M, Preis M, Gerber F, Pöllinger N, Breitkreutz J, Weitschies W. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations. Drug Dev Ind Pharm. 2015;41:540–51.
Kim J-I, Cho S-M, Cui J-H, Cao Q-R, Oh E, Lee B-J. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. Int J Pharm. 2013;455:31–9.
Noorjahan A, Amrita B, Kavita S. In vivo evaluation of taste masking for developed chewable and orodispersible tablets in humans and rats. Pharm Dev Technol. 2014;19:290–5.
Desai J, Thakkar H. Enhanced oral bioavailability and brain uptake of Darunavir using lipid nanoemulsion formulation. Colloids Surf B: Biointerfaces. 2019;175:143–9.
Lockman PR, Koziara JM, Mumper RJ, Allen D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target. 2004;12:635–41.
Onodera A, Nishiumi F, Kakiguchi K, Tanaka A, Tanabe N, Honma A, et al. Short-term changes in intracellular ROS localisation after the silver nanoparticles exposure depending on particle size. Toxicol Rep. 2015;2:574–9.
Park MVDZ, Neigh AM, Vermeulen JP, de la Fonteyne LJJ, Verharen HW, Briedé JJ, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011;32:9810–7.
Tantra R, Schulze P, Quincey P. Effect of nanoparticle concentration on zeta-potential measurement results and reproducibility. Particuology. 2010;8:279–85.
Mahl D, Diendorf J, Meyer-Zaika W, Epple M. Possibilities and limitations of different analytical methods for the size determination of a bimodal dispersion of metallic nanoparticles. Colloids Surf A Physicochem Eng Asp. 2011;377:386–92.
Wang S, Shi Y, Tu Z, Zhang L, Wang H, Tian M, et al. Influence of soy lecithin concentration on the physical properties of whey protein isolate-stabilized emulsion and microcapsule formation. J Food Eng. 2017;207:73–80.
Arancibia C, Riquelme N, Zúñiga R, Matiacevich S. Comparing the effectiveness of natural and synthetic emulsifiers on oxidative and physical stability of avocado oil-based nanoemulsions. Innov Food Sci Emerg Technol. 2017;44:159–66.
Bykkam S, Ahmadipour M, Narisngam S, Kalagadda VR, Chidurala SC. RETRACTED: extensive studies on X-ray diffraction of green synthesized silver nanoparticles. Adv Nanoparticles. 2015;04:1–10.
Kelidari HR, Saeedi M, Akbari J, Morteza-Semnani K, Gill P, Valizadeh H, et al. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surf B: Biointerfaces. 2015;128:473–9.
El-Houssiny AS, Ward AA, Mostafa DM, Abd-El-Messieh SL, Abdel-Nour KN, Darwish MM, et al. Drug-polymer interaction between glucosamine sulfate and alginate nanoparticles: FTIR, DSC and dielectric spectroscopy studies. Adv Nat Sci Nanosci Nanotechnol. 2016;7. https://doi.org/10.1088/2043-6262/7/2/025014.
Wu T, Wang G, Shi C, Li J, Zhao N, Dong Z, et al. Development and evaluation of orally disintegrating tablets containing the mosapride resin complex. Acta Pharma. 2018;68:159–70.
Afoakwa EO, Paterson A, Fowler M. Factors influencing rheological and textural qualities in chocolate - a review. Trends Food Sci Technol. 2007;18:290–8.
Cheung LC, Nguyen M, Tang E, von Ungern Sternberg BS, Salman S, Tuleu C, et al. Taste evaluation of a novel midazolam tablet for pediatric patients: in vitro drug dissolution, in vivo animal taste aversion and clinical taste perception profiles. Int J Pharm. 2018;535:194–200.
Acknowledgments
We highly acknowledge Mr. Muhammad Mohsin, Prof. Dr. Shahiq-Uz-Zaman, and Dr. Humaira from the Riphah Institute of Pharmaceutical Sciences for their support and lab facilities. We also endorse Abbasi Chemicals Lahore, Paramount Pharmaceuticals, Islamabad, for their chemicals as gift samples used in this project. We are thankful to Dr. Zia-Ur-Rahman and Miss. Humaira Khalid from Pakistan Council of Scientific and Industrial Research for Karl Fischer Analysis.
Funding
We express our thanks to the office of the Dean, Biological Sciences, Quaid-i-Azam University, who funded this project under URF (University Research Fund; NO. DFBS/2019-3693).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Naqvi, R.F., Khan, A., Umer, M.F. et al. Design and Optimization of Novel Taste-Masked Medicated Chocolates of Dextromethorphan with In vitro and In vivo Taste Evaluation. J Pharm Innov 17, 376–390 (2022). https://doi.org/10.1007/s12247-020-09511-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12247-020-09511-8